Marijn Verhoef to share insights on measuring patient reach at workshop on access and impact measurement

The Bill & Melinda Gates Foundation will host the final workshop in a three-part series aimed at standardising access and impact measurement in the biopharmaceutical industry. This initiative is part of a broader effort to map existing Access and Impact reporting frameworks within the sector, with the goal of improving alignment among stakeholders. By promoting a core set of concepts and metrics, the project seeks to reduce fragmentation and minimise redundancy, ensuring greater consistency in reporting practices. 

Building on the momentum of the previous two sessions, the final workshop in the series will focus on delivering concrete outputs that can inform future updates to sustainability reporting standards. Attendees will include representatives from companies, regulators, investors, governments, academia, multilateral organisations, and standard setters in capital markets. 

During the workshop, Marijn will join a roundtable discussion to share key findings and recommendations from the Foundation’s 2024 Access to Medicine Index, which, in comparison with the previous iterations, includes a more rigorous assessment of companies’ efforts to track and report on patient reach. He will discuss the varying performance of companies in Governance of Access and Product Delivery, while also highlighting their mixed approaches in measuring patient reach. 

About the Gates Foundation

TheGates Foundation is a nonprofit organisation that aims to fight poverty, disease and inequity around the world through its work. It is also a funder of the Access to Medicine Foundation. For more information, click here.